Primary B-CLL Resistance to NK Cell Cytotoxicity can be Overcome In Vitro and In Vivo by Priming NK Cells and Monoclonal Antibody Therapy-Reference-Cited by-同舟云学术

Primary B-CLL Resistance to NK Cell Cytotoxicity can be Overcome In Vitro and In Vivo by Priming NK Cells and Monoclonal Antibody Therapy

Published:2012-02-09 Issue:3 Volume:32 Page:632-646
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Veuillen Caroline,Aurran-Schleinitz Thérèse,Castellano Rémy,Rey Jérôme,Mallet Françoise,Orlanducci Florence,Pouyet Laurent,Just-Landi Sylvaine,Coso Diane,Ivanov Vadim,Carcopino Xavier,Bouabdallah Réda,Collette Yves,Fauriat Cyril,Olive Daniel

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10875-011-9624-5.pdf

Reference74 articles.

1. Cramer P, Hallek M, et al. Prognostic factors in chronic lymphocytic leukemia—what do we need to know? Nat Rev Clin Oncol. 2011;8:38–47.

2. Packham G, Stevenson FK, et al. Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology. 2005;114:441–9.

3. Kolb J-P, Kern C, Quiney C, Roman V, Billard C, et al. Re-establishment of a normal apoptotic process as a therapeutic approach in B-CLL. Curr Drug Targets Cardiovasc Haematol Disord. 2003;3:261–86.

4. Dasanu CA, Alexandrescu DT, et al. Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia. MedGenMed. 2007;9:35.

5. Hamblin AD, Hamblin TJ, et al. The immunodeficiency of chronic lymphocytic leukaemia. Br Med Bull. 2008;87:49–62.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NK Cell Degranulation Triggered by Rituximab Identifies Potential Markers of Subpopulations with Enhanced Cytotoxicity toward Malignant B Cells;International Journal of Molecular Sciences;2024-08-18

2. Evaluation of infectious morbidity due to BTK inhibitors in indolent B-cell lymphomas: latest research findings and systematic analysis;Expert Opinion on Pharmacotherapy;2024-07-23

3. Potential Effect of Extracellular Vesicles in Clinical Settings of Lymphoma;Indian Journal of Clinical Biochemistry;2023-10-14

4. XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression;Leukemia;2023-08-01

5. Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease;International Journal of Molecular Sciences;2023-05-31